CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease

<p>Background & Aims</p> <p>End points to determine the efficacy and safety of medical therapies for Crohn’s disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in current outcome measures, harmonizing end points in a core outcome set for randomized c...

Повний опис

Бібліографічні деталі
Автори:	Ma, C, Hanzel, J, Panaccione, R, Sandborn, WJ, D'Haens, GR, Ahuja, V, Atreya, R, Bernstein, CN, Bossuyt, P, Bressler, B, Bryant, RV, Cohen, B, Colombel, J-F, Danese, S, Dignass, A, Dubinsky, MC, Fleshner, PR, Gearry, RB, Hanauer, SB, Hart, A, Kotze, PG, Kucharzik, T, Lakatos, PL, Leong, RW, Magro, F, Panés, J, Peyrin-Biroulet, L, Ran, Z, Regueiro, M, Singh, S, Spinelli, A, Steinhart, AH, Travis, SP, van der Woude, CJ, Yacyshyn, B, Yamamoto, T, Allez, M, Bemelman, WA, Lightner, AL, Louis, E, Rubin, DT, Scherl, EJ, Siegel, CA, Silverberg, MS, Vermeire, S, Parker, CE, McFarlane, SC, Guizzetti, L, Smith, MI, Casteele, NV, Feagan, BG, Jairath, V
Інші автори:	CORE-IBD Collaborators
Формат:	Journal article
Мова:	English
Опубліковано:	Elsevier 2022

CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease

Схожі ресурси